TWO SIGMA INVESTMENTS, LP - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 53 filers reported holding ENZO BIOCHEM INC in Q3 2013. The put-call ratio across all filers is 5.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2021$150,000
-12.3%
42,327
-21.6%
0.00%
Q2 2021$171,000
+16.3%
53,964
+25.9%
0.00%
Q1 2021$147,000
-52.0%
42,859
-63.1%
0.00%
-100.0%
Q4 2019$306,000
-47.7%
116,190
-28.5%
0.00%
-50.0%
Q3 2019$585,000
+64.8%
162,611
+54.4%
0.00%
+100.0%
Q2 2019$355,000
+87.8%
105,323
+52.3%
0.00%0.0%
Q1 2019$189,000
-45.8%
69,164
-44.9%
0.00%0.0%
Q4 2018$349,000
-21.4%
125,562
+16.5%
0.00%0.0%
Q3 2018$444,000
+13.0%
107,739
+42.1%
0.00%0.0%
Q2 2018$393,000
+4.8%
75,810
+10.9%
0.00%0.0%
Q1 2018$375,000
+37.4%
68,376
+104.4%
0.00%0.0%
Q4 2017$273,000
+133.3%
33,460
+200.4%
0.00%
Q3 2017$117,000
-94.4%
11,137
-94.1%
0.00%
-100.0%
Q2 2017$2,080,000
+53.4%
188,385
+16.3%
0.01%
+60.0%
Q1 2017$1,356,000
+81.3%
162,035
+50.4%
0.01%
+66.7%
Q4 2016$748,000
-8.4%
107,753
-32.9%
0.00%0.0%
Q3 2016$817,000
-33.7%
160,602
-22.2%
0.00%
-40.0%
Q2 2016$1,233,000
+199.3%
206,517
+128.0%
0.01%
+150.0%
Q1 2016$412,000
+21.9%
90,589
+20.7%
0.00%0.0%
Q4 2015$338,000
+428.1%
75,058
+254.1%
0.00%
Q2 2015$64,000
-37.9%
21,194
-39.2%
0.00%
-100.0%
Q1 2015$103,000
-10.4%
34,883
+59.3%
0.00%0.0%
Q2 2014$115,000
-63.7%
21,900
-79.9%
0.00%
-50.0%
Q4 2013$317,000
+387.7%
108,772
+322.5%
0.00%
Q3 2013$65,00025,7440.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2013
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders